Introduction
The chromosome aberration test has been widely used for evaluating the genotoxic potential of chemicals and has been designated as one of the standard batteries for many registration guidelines in the world. However, the results of the tests seem to diŠer among laboratories where various kinds of cell lines are used. Some elaborate works have been done to elucidate the factors which contribute to these diŠerences, using CHL/IU and CHO-WBL cells (1, 2) . It was concluded that diŠerences in the test protocols, such as the sampling time and treatment time, are the main factors aŠecting the discrepancies of the results, and negative results for some chemicals in the test using CHO-WBL cells turned to positive when using the same protocol with CHL/IU cells. However, the study was performed with a very limited set of chemicals.
Antimycin A is well known as a mitochondrial inhibitor (Complex III blocker) (3, 4) , and carcinogenicity of this compound is unknown. It is not mutagenic in Ames test (unpublished results, by Izumi Ogawa), nor in mouse lymphoma Tk assay (5) . However, no reports are available about the clastogenicity in CHL/IU or CHO-WBL cells for this compound. So, in the present study, we conducted chromosome aberration tests using these two cell lines and found that the results were diŠerent between these two cell lines. We examined whether these diŠerences were caused by diŠerent test conditions, or by diŠerent congenital characteristics of these cells, using various test protocols. In addition, we investigated whether antimycin A has potential to directly interact with DNA by using the comet assay to assess the genotoxicity of this compound.
Materials and Methods
Chemicals: Antimycin A (Cas No.: 1397-94-0) was purchased from Sigma-Aldrich Chemicals Inc. (St. Louis, USA). Dimethyl sulfoxide (DMSO) and demecolcine (hanks' balanced solution, 10 mg/mL) were purchased from Wako Ltd. (Osaka, Japan). Regular (GP-42) agarose and low melting point (LGT) agarose were purchased from Nacalai Tesque Co., Ltd., (Kyoto, Japan).
Cell lines and their treatments with chemicals: CHL/IU cells were originally established from the lung of a female newborn Chinese hamster. The cells were cloned by Dr. M. Ishidate Jr and Dr. Udakoji and maintained at the National Institute of Health Sciences, Tokyo, Japan (NIHS). We obtained the cells from NIHS in 1985. Since then, the cells have been maintained and re-cloned several times. The chromosome modal number was 25 and the doubling time was about 14 h. Cultures were grown in Eagle's minimal essential medium (MEM) (Nissui Pharmaceutical Co., Ltd. Chromosome aberration tests in CHL cells: Two days before the treatment, cell suspension was plated at 4.8×10 4 /4 mL in 60 mm disposable plastic dishes. On the treatment of the cells in logarithmic phase, medium was replaced by ‰esh MEM medium with calf serum, with or without S9 mix (Table 1) .
Chromosome aberration tests in CHO cells: A day before the treatment, cell suspension was plated at 2×10 5 /4 mL in 60 mm disposable plastic dishes. On the treatment of the cells in logarithmic phase, medium was replaced by ‰esh McCoy's 5A medium. For antimycin treatment, we used three protocols, protocol I, II and III. Protocol I is same as the standard protocol for CHO except for extension of recovery time. In protocol II, the treatment time, and composition and concentration in the treatment medium of S9 mix were modiˆed to that used for CHL cells. In protocol III, continuous treatment (24 h) was conducted using McCoy's 5A medium with 10z fetal calf serum. The major diŠer-ences in the experimental protocols are summarized in Table 1 . S9 purchased from Oriental Yeast Co. Ltd (Tokyo, Japan) was prepared from the livers of male Sprague-Dawley rats treated with phenobarbital and 5,6-benzo‰avone. The protein concentration was 30 mg/mL. Maximum treatment dose for antimycin A was selected at below 50z cell con‰uence measured by counting the tripan blue excluded viable cells when harvesting. In all the tests, demecolcine (0.2 mg/mL in nal concentration) was added to the culture medium 2 h before harvesting. The cells were harvested using the trypsin method, and the cytotoxicity was evaluated as the relative cell growth by counting the viable cells in the cell suspension that was sampled from each dish. In protocol II without S9 mix, the toxicity was demonstrated by the relative mitotic index as well as the relative cell growth because some cell cycle delays seemed to occur. All treatments were performed using duplicated dishes. Chromosome preparations were made using the conventional air-drying technique. The frequencies of structural aberration and polyploidy in the treated cells were compared with the concurrent solvent control (100 cells per dish). If the aberrations signiˆcantly increased, as assessed by Fisher's exact test (pº0.05), without steep and heavy toxicity, the result was considered positive.
Comet assay: The composition and concentration in the treatment medium of S9 mix were the same as those used in the chromosome aberration test for CHL cells. In addition, the treatment medium contained the serum that was used for the respective cell cultures. The maximum treatment dose was selected by taking into consideration the result of the chromosome aberration test, as well as recommendation by IWGT that the dose of 70-80z cell con‰uence should be the maximum (6) . After 3 h treatment, cells were harvested by exposure to trypsin-EDTA solution (trypsin 0.05z, EDTA 4Na 1 mg/mL) for 3 min followed by gentle pipetting. Immediately after, the cells were layered in the agarose 
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Chromosome Aberrations Induced by Antimycin A slides. The cytotoxicity was evaluated by counting the viable cells in the cell suspension, which was sampled from each dish. We followed Dr. Sasaki's method for preparing the comet slides (7, 8) . The slides were placed in a chilled lysing solution (pH 10) and kept at 09 C in the dark for 60 min to lyse the cell/nucleus membrane, and subsequently placed on a horizontal gel electrophoresis platform, covered with a chilled alkaline solution (pH 13), and left in the dark at 49 C for 20 min to unwind DNA strands. The DNA underwent electrophoresis for 30 min at 1 V/cm (250-300 mA). The slides were gently rinsed with 400 mM Trizma-HCl (pH 7.5) to neutralize the excess alkali. Each slide was stained with 50 mL of ethidium bromide solution (20 mg/mL). Fifty nuclei per dish were examined at ×200 magniˆcation using a ‰uorescence microscope. The comet images were scanned into an image analyzer (SCG32; Keiodenshi Industries, Ltd., Tokyo, Japan) to measure the tail moment. The average DNA tail moment of the treatment group was compared with the concurrent solvent control by Dunnett's multiple comparison test. 
Results
Induction of chromosome structural aberrations in CHL cells: The structural aberration frequency increased by 15z when the cells were treated with 50 mg/mL antimycin A, in the presence of S9 mix. However, there was no increase in aberration frequency with any doses without S9 mix. Polyploidy did not increase signiˆcantly at any doses with or without S9 mix ( Table 2) .
Induction of polyploidy but no structural aberrations in CHL cells: Although we have routinely used 17 h as the recovery time for the conventional CHO protocol, severe mitotic delays were seen in the cells treated with antimycin A after 17 h (data not shown). Therefore, we delayed harvesting until 23 h after treatment in protocol I. By protocol I, structural aberration frequencies did not increase signiˆcantly at any doses with or without S9 mix, except the highly toxic dose (relative cell growth of 25z) where the frequencies were slightly increased by 4z. The frequency of polyploidy increased signiˆcantly when S9 mix was present, by 4.5z and 3.5z at 10 and 20 mg/mL antimycin A, respectively, at which moderate cytotoxicity appeared. More than half of these cells with polyploidy were endoreduplicated cells (Table 2) .
In protocol II, structural aberration frequencies did not increase signiˆcantly at any doses either with or without S9 mix. The frequencies of polyploidy increased signiˆcantly in the treatments with or without S9 mix. With S9 mix, the frequency of polyploidy reached 9.0z at 20 mg/mL antimycin A. These polyploid cells also contained some amount of endoreduplicated cells. Without S9 mix, the frequency of polyploidy also increased by 9z at 0.5 mg/mL. However, these cells contained only 0.5z of endoreduplicated cells. In the treatment without S9 mix, the toxicity demonstrated by the relative mitotic index was higher than that demonstrated by the relative cell growth, which revealed that some cell cycle delays seemed to occur during the treatment (Table 2) .
No increases in the frequencies of cells with structural aberration nor polyploidy were shown by protocol III (Table 2) .
It was concluded that antimycin A induced polyploidy, but not structural aberrations, in CHO cells.
Comet assay: Comet assays were performed to clarify whether chromosome aberrations were results of DNA-reactivity of antimycin A or not. Tail moment in both CHL and CHO cells did not show any signiˆcant increase at any doses of antimycin A, although positive control, B[a]P and MMS gave higher tail moment values than those of controls (Table 3 ).
Discussion
We found that antimycin A induced chromosome structural aberration in CHL cells but did not in CHO cells, under the conditions widely used for CHO (protocol I). However, antimycin A induced polyploidy, including endoreduplication, in CHO cells but did not in CHL cells. These diŠerences between these two cell lines were also seen in protocol II for CHO cells, with the same conditions as those for CHL cells, such as longer treatment time, diŠerent sampling time and a higher concentration of S9 than those in protocol I, as routinely used in European countries and the USA. Therefore, it can be considered that the diŠerences in the responses of chromosome aberration stem from some congenital diŠerences between these cells. Moreover, considering the fact that antimycin A gave a negative result in the Ames test and mouse lymphoma Tk assay, as well as the comet assay conducted in the present study, chromosome aberrations induced by antimycin A do not seem to be caused by direct interaction of antimycin A with DNA.
Our results showed that chromosome structural aberration in CHL cells appeared with increasing cytotoxicity, which seemed to have a threshold of cytotoxicity accompanied by clastogenicity. It has been reported that chromosome aberrations that are observed only above a certain threshold dose, associated with cytotoxicity, could be caused by a non-DNAreactive mechanism, which was not expected to follow single hit linear kinetics, as would be observed with DNA-reactive chemicals (9) . However, at present the reason why structural aberrations were not induced in CHL cells without S9 mix is not known.
In CHO cells, it could be di‹cult to attribute the mechanism of polyploidy formation to a simple spindle poison. If antimycin A works as a typical spindle poison, polyploidy would also appear in CHL cells. However, there was no induction of polyploidy in CHL cells, and almost half of the polyploid cells were endoreduplicated cells in CHO cells. The mechanism of endoreduplication, a result of the occurrence of two successive rounds of DNA replication without intervening mitosis, is poorly understood. Recently, there have been some reports that this mechanism is related to topoisomerase II, an enzyme capable of decatenating replicated DNA strands after cell replication (10, 11) . When this enzyme malfunctions, it might be possible for some cells to skip anaphase and initiate a new cell cycle, leading to a further round of replication (12) . Considering the result that the endoreduplication did not appear in CHL cells in this study, it can be speculated that there are some diŠerences between these cells with regard to topoisomerase II activity. However, further work will be required to clarify this.
As discussed above, the chromosome aberrations induced in these cells may be derived from a non-DNAreactive mechanism, such as DNA synthesis, protein synthesis or a cell cycle disorder, which is related to a certain enzymes.
Many generally-known DNA-reactive compounds used as positive controls in the chromosome aberration tests express equivalent positive responses in both cells.
In addition, nine derivatives of phenylenediamine or chlorophenol, which are mutagens or tumorigens, were reported to turn out indistinguishable positive when tested using the same protocol for the CHL and CHO cell systems (1, 2) . These facts also imply the prediction that the diverse responses of antimycin A for two cell lines might come from the non-DNA-reactive mechanism on the clastogenicity.
Antimycin A, a mitochondrial inhibitor, is known to interfere with ATP production, which means that nonspeciˆc inhibition of the activities of ATP-dependent enzymes could occur at any time and place. This inhibition might be related to the non-DNA-reactive mechanism for inducing chromosome aberration. It was reported that CHO-WBL cells have mutant p53 with mutant function and CHL cells have wild type p53 associated with abnormal function, which leads to a lack of G1 check point or G1 delay in their cell cycles (13) . It is speculated that, in such cells with poor control of the cell cycle, the ATP-dependent enzyme disorders attributable to energy depletion would be enhanced much more than in normal cells.
It can be noticed that antimycin A seems to be detoxiˆed because the concentrations in the treatment with S9 mix were higher than those without S9 mix, however, how the metabolized form is related to the expression of the clastogenicity is unknown.
